CD4 and T-cell leukemia: Pinz et al. constructed a CD4 CAR on NK-92 cell lines that specifically eliminated diverse CD4+ human T-cell leukemia/lymphoma cell lines and patient samples ex vivo and efficiently targeted and killed KARPAS-299 cells in vivo [52].